ArticleAmyotrophic lateral sclerosis & frontotemporal degeneration2015

A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement.

Zachary Macchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.